|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2002
Elevated nitrite in breath condensates of children with respiratory disease
1 Swiss Paediatric Respiratory Physiology Research Group, Dept of Respiratory Medicine and 2 Division of Immunology, University Children's Hospital, Zürich, and 3 Dept of Respiratory Medicine, University Children's Hospital, Bern, Switzerland. 4 Wilhelminenspital der Stadt Wien, Austria
CORRESPONDENCE: G. Hall, Respiratory Medicine, Princess Margaret Hospital for Children, GPO Box D184, Perth, 6840, Australia. Fax: 61 893408181
Keywords: airway inflammation, breath condensates, children, nitric oxide, respiratory disease
Received: December 1, 2000
Accepted October 17, 2001
This study was supported by NH and MRC (Australia), Swiss CF Foundation, AstraZeneca (Switzerland), Swiss National Research Foundation. W. Formanek was subsidized by a grant from the Ärzteverein Wilhelminenspital, Vienna.
The aim of the study was to determine the differences in nitrite, in the exhaled breath condensates of healthy children and those children with asthma, cystic fibrosis (CF) and nonasthmatic, episodic cough.
Breath condensates were obtained from 66 children (43 males:23 females, 3.1–16 yrs) and included 29 asthmatics, 12 clinically stable CF patients, 12 children with cough but not asthma and 13 healthy volunteers. The collected condensate was assayed colourimetrically using the Griess reaction to determine nitrite concentrations.
Patients with CF (median: 5–95% percentiles; 2.02: 0.43–6.37 µM) or asthma (2.10: 0.63–5.45 µM) had significantly higher levels of nitrite compared to healthy subjects (0.41: 0.13–1.83 µM; p<0.05) or subjects with cough (0.75: 0.03–1.75 µM; p<0.05).
Airway inflammation, as assessed by the nitrite in breath condensates, is present in children with asthma and cystic fibrosis, but not those children with nonasthmatic, episodic cough. Nitrite can be conveniently, cheaply and rapidly measured in breath condensates of children as young as 3 yrs of age, and may prove useful for the assessment of airway inflammation in children with respiratory disease.
This article has been cited by other articles:
|
|
 |
|
  A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu Recommendations for the management of cough in adults Thorax, September 1, 2006; 61(suppl_1): i1 - i24. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Goldbart, J. Krishna, R. C. Li, L. D. Serpero, and D. Gozal Inflammatory Mediators in Exhaled Breath Condensate of Children With Obstructive Sleep Apnea Syndrome. Chest, July 1, 2006; 130(1): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Moeller, F Horak Jr, C Lane, D Knight, A Kicic, S Brennan, P Franklin, J Terpolilli, J H Wildhaber, and S M Stick Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis Thorax, June 1, 2006; 61(6): 514 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Horvath The exhaled biomarker puzzle: bacteria play their card in the exhaled nitric oxide-exhaled breath condensate nitrite game Thorax, March 1, 2005; 60(3): 179 - 180. [Full Text] [PDF]
|
|
|
|
|
|
H Marteus, D C Tornberg, E Weitzberg, U Schedin, and K Alving Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation Thorax, March 1, 2005; 60(3): 219 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Baraldi, L Ghiro, V Piovan, S Carraro, F Zacchello, and S Zanconato Safety and success of exhaled breath condensate collection in asthma Arch. Dis. Child., April 1, 2003; 88(4): 358 - 360. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |